2017 Advisory Committee Tentative Meetings
The tentatively scheduled advisory committee meetings will provide both advisory committee members and the public with the opportunity, in advance, to schedule attendance at FDA's upcoming advisory committee meetings. Changes to this list will be posted on this site on a monthly basis with meetings occurring in the upcoming months. FDA will continue to publish a Federal Register notice 15 days in advance of each upcoming advisory committee meeting, to announce the meeting (21 CFR 14.20).
The following list announces FDA's tentatively scheduled advisory committee meetings for 2017. You may also obtain up-to-date information by calling the Advisory Committee Information Line 1-800-741-8138 (301-443-0572 in the Washington, DC area).
| Committee Name | Tentative Date(s)of Meeting(s) |
|---|---|
| OFFICE OF THE COMMISSIONER | |
| Pediatric Advisory Committee | September 11-12 |
| Risk Communication Advisory Committee | Date(s), if needed, to be determined |
| Science Board to the FDA | Date(s), if needed, to be determined |
| CENTER FOR BIOLOGICS EVALUATION AND RESEARCH | |
| Allergenic Products Advisory Committee | Date(s), if needed, to be determined |
| Blood Products Advisory Committee | Date(s), if needed, to be determined |
| Cellular, Tissue and Gene Therapies Advisory Committee | Date(s), if needed, to be determined |
| Vaccines and Related Biological Products Advisory Committee | May 17 July 28 |
| CENTER FOR DRUG EVALUATION AND RESEARCH | |
| Anesthetic and Analgesic Drug Products Advisory Committee | Date(s), if needed, to be determined |
| Antimicrobial Drugs Advisory Committee | Date(s), if needed, to be determined |
| Arthritis Advisory Committee | Date(s), if needed, to be determined |
| Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs) | Date(s), if needed, to be determined |
| Cardiovascular and Renal Drugs Advisory Committee | Date(s), if needed, to be determined |
| Dermatologic and Ophthalmic Drugs Advisory Committee | Date(s), if needed, to be determined |
| Drug Safety and Risk Management Advisory Committee | Date(s), if needed, to be determined |
| Endocrinologic and Metabolic Drugs Advisory Committee | Date(s), if needed, to be determined |
| Gastrointestinal Drugs Advisory Committee | Date(s), if needed, to be determined |
| Medical Imaging Drugs Advisory Committee | May 10 |
| Nonprescription Drugs Advisory Committee | Date(s), if needed, to be determined |
| Oncologic Drugs Advisory Committee | May 24, May 25 |
| Peripheral and Central Nervous System Drugs Advisory Committee | Date(s), if needed, to be determined |
| Advisory Committee for Pharmaceutical Science and Clinical Pharmacology | Date(s), if needed, to be determined |
| Pharmacy Compounding Advisory Committee | May 8 and 9 |
| Psychopharmacologic Drugs Advisory Committee | Date(s), if needed, to be determined |
| Pulmonary-Allergy Drugs Advisory Committee | Date(s), if needed, to be determined |
| CENTER FOR DEVICES AND RADIOLOGICAL HEALTH | |
| Medical Devices Advisory Committee (Comprised of 18 Panels) | |
| Anesthesiology and Respiratory Therapy Devices Panel | Date(s), if needed, to be determined |
| Circulatory System Devices Panel | Date(s), if needed, to be determined |
| Clinical Chemistry and Clinical Toxicology Devices Panel | Date(s), if needed, to be determined |
| Dental Products Panel | Date(s), if needed, to be determined |
| Ear, Nose, and Throat Devices Panel | Date(s), if needed, to be determined |
| Gastroenterology-Urology Devices Panel | Date(s), if needed, to be determined |
| General and Plastic Surgery Devices Panel | Date(s), if needed, to be determined |
| General Hospital and Personal Use Devices Panel | Date(s), if needed, to be determined |
| Hematology and Pathology Devices Panel | Date(s), if needed, to be determined |
| Immunology Devices Panel | Date(s), if needed, to be determined |
| Medical Devices Dispute Resolution Panel | Date(s), if needed, to be determined |
| Microbiology Devices Panel | Date(s), if needed, to be determined |
| Molecular and Clinical Genetics Panel | Date(s), if needed, to be determined |
| Neurological Devices Panel | Date(s), if needed, to be determined |
| Obstetrics and Gynecology Devices Panel | Date(s), if needed, to be determined |
| Ophthalmic Devices Panel | October 27 |
| Orthopaedic and Rehabilitation Devices Panel | Date(s), if needed, to be determined |
| Radiological Devices Panel | Date(s), if needed, to be determined |
| Device Good Manufacturing Practice Advisory Committee | Date(s), if needed, to be determined |
| National Mammography Quality Assurance Advisory Committee | Date(s), if needed, to be determined |
| Patient Engagement Advisory Committee | October 11-12 |
| Technical Electronic Product Radiation Safety Standards Committee | Date(s), if needed, to be determined |
| CENTER FOR FOOD SAFETY AND APPLIED NUTRITION | |
| Food Advisory Committee | Date(s), if needed, to be determined Date(s), if needed, to be determined Date(s), if needed, to be determined |
| CENTER FOR TOBACCO PRODUCTS | |
| Tobacco Products Scientific Advisory Committee | December 11-12 |
| NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH (NCTR) | |
| Science Advisory Board to NCTR | November 6-7 |